Exact Sciences stock was up nearly 3 percent Friday on supposed Food and Drug Administration approval of emergency use of its in-house test for COVID-19, according to SeekingAlpha.com.
The expected approval has not yet appeared on the FDA’s website.
However, the FDA did announce that it has given emergency use authorization to Laboratory Corporation of America for its at-home COVID-19 test.
